Gerry McLachlan
Impact in
- Equine top 2%
-
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Inhalation and Respiratory Drug Delivery
Papers in
-
- Cystic Fibrosis Research Advances 12
- Neonatal Respiratory Health Research 10
- Tracheal and airway disorders 5
- Co-authors
- David J. PorteousBarbara StevensonEric W.F.W. AltonLaura GlendinningDavid CollieJulia R. DorinDonald J. DavidsonHazel Davidson‐Smith
- Journals
- Gene Therapy (4 papers)PLoS ONE (4 papers)Human Gene Therapy (3 papers)Equine Veterinary Journal (3 papers)Applied and Environmental Microbiology (2 papers)
- Partner nations
- United KingdomMalaysiaUnited States
In The Last Decade
Gerry McLachlan
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 114
- Equine 49
- Pulmonary and Respiratory Medicine 550
- Genetics 435
- Microbiology 90
- Molecular Biology 871
Countries citing papers authored by Gerry McLachlan
This map shows the geographic impact of Gerry McLachlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerry McLachlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerry McLachlan more than expected).
Fields of papers citing papers by Gerry McLachlan
This network shows the impact of papers produced by Gerry McLachlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerry McLachlan. The network helps show where Gerry McLachlan may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerry McLachlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 17 | |
| 5 | 2021 | 9 | |
| 6 | 2020 | 21 | |
| 7 | 2017 | 35 | |
| 8 | 2015 | 12 | |
| 9 | 2014 | 3 | |
| 10 | 2014 | 18 | |
| 11 | 2014 | 44 | |
| 12 | 2013 | 14 | |
| 13 | Quantifying non-viral gene transfer by real-time PCR: a cautionary tale | 2009 | 0 |
| 14 | 2008 | 63 | |
| 15 | 2004 | 41 | |
| 16 | 2002 | 35 | |
| 17 | 1997 | 236 | |
| 18 | 1995 | 117 | |
| 19 | 1993 | 299 | |
| 20 | A foreign view of the United States under MEDICAID and MEDICARE. | 1976 | 1 |
About Gerry McLachlan
Gerry McLachlan is a scholar working on Microbiology, Pulmonary and Respiratory Medicine, Equine, Genetics and Infectious Diseases, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (12 papers), Neonatal Respiratory Health Research (10 papers), Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (7 papers), Gut microbiota and health (6 papers), Viral gastroenteritis research and epidemiology (6 papers), Tracheal and airway disorders (5 papers) and CRISPR and Genetic Engineering (5 papers). The work is most often cited by research in Equine (49 citations), Pulmonary and Respiratory Medicine (550 citations), Genetics (435 citations), Microbiology (90 citations) and Molecular Biology (871 citations). Gerry McLachlan has collaborated with scholars based in United Kingdom, Malaysia and United States. Frequent co-authors include David J. Porteous, Barbara Stevenson, Eric W.F.W. Alton, Laura Glendinning, David Collie, Julia R. Dorin, Donald J. Davidson, Hazel Davidson‐Smith, Paul Dickinson and Stephen C. Hyde. Their work appears in journals such as Gene Therapy, PLoS ONE, Human Gene Therapy, Equine Veterinary Journal and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.